IQVIA Holdings Inc. (IQV)

238,62 +7,28 (+3,15%) Börsenschluss: 04:00PM EDT

IQVIA Holdings Inc.

2400 Ellis Road
Durham, NC 27703
United States
919 998 2000
https://www.iqvia.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 87.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Ari Bousbib	CEO & Chairman	7,15M	N/A	1961
Mr. Ronald E. Bruehlman	Executive VP & CFO	2,14M	N/A	1961
Mr. Eric M. Sherbet	Executive VP, General Counsel & Secretary	1,37M	N/A	1964
Mr. W. Richard Staub III	President of Research & Development Solutions	886,44k	3,59M	1963
Mr. Kevin C. Knightly	President of Corporate Strategy & Enterprise Networks	1,24M	2,81M	1961
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Chief Accounting Officer	N/A	N/A	1985
Mr. Jim Berkshire	Executive Vice President of Global Technology & Operations	N/A	N/A	N/A
Dr. Jeffrey A. Spaeder M.D.	Senior VP, Global Chief Medical & Scientific Officer	N/A	N/A	N/A
Kerri Joseph	SVP of Investment Relation & Treasury	N/A	N/A	N/A
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Corporate Governance

IQVIA Holdings Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 7. Die grundlegenden Scores sind Audit: 4, Vorstand: 8, Shareholderrechte: 7, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.